基本信息
views: 13
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Mayur Parmar is an assistant professor in the Department of Basic Sciences at the Dr. Kiran C. Patel College of Osteopathic Medicine. He is passionate about teaching pharmacology and physiology to medical students.
As a neuroscientist, Parmar seeks to understand better the pathological mechanisms (molecular, genetic, and cellular) underlying neurodegenerative diseases (Alzheimer's and Parkinson's) and the therapeutic interventions that halt disease progression. His professional research expertise includes multidisciplinary areas of biological sciences, including pharmacology, toxicology, and molecular/cellular biology, with broad research experience in neuroscience.
Parmar received his Ph.D. in Pharmacology and Toxicology. His doctoral dissertation work focused on understanding the modulation of MAPK kinase signaling in dopaminergic brain regions (such as substantia nigra, striatum, and ventral tegmental area) during normal aging. He discovered that ERK5 is vital for the survival of dopamine neurons. Afterward, he went to the Appel Alzheimer's Disease Research Institute at Weill Cornell Medical College, New York, to work as a researcher in the field of neurodegenerative disease. At Cornell, he researched the role of apolipoprotein E in amyloid and tau pathologies using an adeno-associated virus gene delivery platform. He was also part of the research that used the anti-tau monoclonal antibody PHF1 to reduce tau pathology in the transgenic mouse AD model.
As a postdoctoral associate at the University of Florida, he focused on research understanding the pathological mechanism of Parkinson's disease and related disorders. Using cellular and preclinical models, he studied various Rab GTPases molecules that may enhance or ameliorate alpha-synuclein and tau pathology. He has extensively studied Rab GTPases' role in tauopathies disorders, such as Alzheimer's and atypical parkinsonism (Parkinson-plus syndromes), including progressive supranuclear palsy. He is also interested in research on understanding the relationship between diabetes and neurodegeneration at the disease and molecular levels.
As an assistant professor, Parmar continues his passion for research in Alzheimer's and Parkinson's disease. Currently, he is interested in evaluating newly synthesized medicinal agents for their ability to prevent tau and synuclein aggregation, thereby, neurodegenerative diseases. Additionally, he has been a reviewer for the National Science Foundation and various peer-review journals.
He is an editor for the journals - Oxidative Medicine and Cellular Longevity, BMC Public Health, and Cureus.
Research Interests
Papers共 52 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Current cancer drug targets (2024)
Neurological Sciencespp.1-12, (2024)
Frederick DeRosier, Cody Hibbs,Kaitlyn Alessi,Inderbir Padda, Jeanette Rodriguez, Swati Pradeep,Mayur S. Parmar
Disease-a-Monthpp.101753, (2024)
Cureusno. 3 (2024): e56025-e56025
Cureusno. 10 (2023)
Elsevier eBooks (2023)
Cited0Views0Bibtex
0
0
European Journal of Pharmacology (2023): 175675-175675
Load More
Author Statistics
#Papers: 48
#Citation: 446
H-Index: 15
G-Index: 21
Sociability: 5
Diversity: 3
Activity: 20
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn